CAXII-IN-3
CAXII-IN-3 is an effective carbonic anhydrase (CA XII) inhibitor with a Ki of 53 nM. CAXII-IN-3 exhibits selective inhibition against multiple human CA subtypes with Kis of 5.3 μM, 75 nM, 1.9 μM, > 10 μM against CA I, CA II, CA IV and CA IX. CAXII-IN-3 mainly inhibits CA II and XII, and reduces aqueous humor production. CAXII-IN-3 exhibits β3-AR agonistic activity, can dilate retinal blood vessels, and improve optic nerve perfusion. CAXII-IN-3 can be used in the research of ocular disorders such as glaucoma[1].
Product Specifications
UNSPSC
12352005
Target
Adrenergic Receptor; Carbonic Anhydrase
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
NC1=CC=C(C=C1)CCNC[C@@H](C2=CC=CC=C2)OC(NC3=CC(C=C4)=C(C=C3)OC4=O)=S
Molecular Formula
C26H25N3O3S
Molecular Weight
459.56
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CA II; CA I; CA IX; CA XII; β adrenergic receptor
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Variable Volume Single Channel Micropipette BPIP-527
![hemoglobin subunit gamma 1 (HBG1) Mouse Monoclonal Antibody [Clone ID: OTI35F4]](https://cdn.genprice.uk/products/937/6868c420994c49e6dc407a09/imageurl/ta815851s.webp)